US Stock MarketDetailed Quotes

STOK Stoke Therapeutics

Watchlist
  • 11.910
  • +0.140+1.19%
Close Nov 27 16:00 ET
  • 11.910
  • 0.0000.00%
Post 16:02 ET
630.84MMarket Cap-5725P/E (TTM)

Stoke Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-25.21%-21.62M
19.83%-17.48M
-15.03%-24.57M
-154.40%-81.07M
7.71%-20.65M
21.73%-17.26M
-9.39%-21.8M
-165.73%-21.36M
52.37%-31.87M
-37.61%-22.37M
Net income from continuing operations
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
-3.59%-104.7M
-5.08%-26.96M
6.01%-24.54M
-24.35%-30.65M
8.54%-22.55M
-17.79%-101.07M
-4.94%-25.66M
Operating gains losses
----
----
----
--1K
----
----
----
----
----
----
Depreciation and amortization
-15.23%540K
-10.31%548K
-5.70%563K
59.70%2.47M
2.46%624K
64.18%637K
102.32%611K
141.70%597K
58.73%1.55M
159.15%609K
Other non cash items
1.24%571K
1.08%562K
0.00%550K
13.62%2.26M
8.66%590K
5.22%564K
4.32%556K
45.89%550K
58.36%1.99M
40.67%543K
Change In working capital
-823.93%-3.24M
-102.80%-30K
20.18%-4.69M
-114.02%-6.03M
75.06%-875K
86.97%-351K
151.56%1.07M
-111.45%-5.88M
93,428.26%43.02M
-224.17%-3.51M
-Change in prepaid assets
216.73%600K
-136.22%-644K
83.29%-349K
110.21%529K
188.55%1.35M
-188.47%-514K
283.11%1.78M
36.05%-2.09M
-81.80%-5.18M
-96.40%-1.53M
-Change in payables and accrued expense
-137.13%-749K
180.80%3.58M
-646.72%-1.92M
9.12%-3.21M
-677.39%-1.15M
249.85%2.02M
-517.64%-4.43M
110.19%351K
-221.85%-3.53M
-94.48%199K
-Change in other working capital
-66.88%-3.09M
-179.61%-2.96M
41.47%-2.42M
-106.48%-3.35M
50.50%-1.08M
3.84%-1.85M
271.52%3.72M
-107.14%-4.14M
--51.74M
---2.18M
Cash from discontinued investing activities
Operating cash flow
-25.22%-21.62M
19.83%-17.48M
-15.03%-24.57M
-154.40%-81.07M
7.71%-20.65M
21.74%-17.26M
-9.39%-21.8M
-165.73%-21.36M
52.37%-31.87M
-37.61%-22.37M
Investing cash flow
Cash flow from continuing investing activities
-305.27%-30M
-476.08%-88.28M
-81.18%9.99M
330.91%105.95M
-34.32%14.77M
-78.27%14.62M
15,977.40%23.47M
139.10%53.09M
39.97%-45.88M
90.64%22.49M
Net PPE purchase and sale
73.11%-103K
94.52%-46K
92.73%-12K
59.21%-1.62M
44.01%-229K
81.13%-383K
-23.02%-839K
80.38%-165K
-230.17%-3.96M
-101.48%-409K
Net investment purchase and sale
-299.34%-29.9M
-462.92%-88.23M
-81.22%10M
356.59%107.56M
-34.49%15M
-78.35%15M
2,836.23%24.31M
139.46%53.25M
44.27%-41.92M
90.83%22.9M
Cash from discontinued investing activities
Investing cash flow
-305.27%-30M
-476.08%-88.28M
-81.18%9.99M
330.91%105.95M
-34.32%14.77M
-78.27%14.62M
15,977.40%23.47M
139.10%53.09M
39.97%-45.88M
90.64%22.49M
Financing cash flow
Cash flow from continuing financing activities
1,351.78%8.16M
251,254.17%120.65M
-96.19%1.72M
14.22%53.01M
16,976.74%7.34M
29.49%562K
-98.60%48K
5.99%45.05M
3,514.41%46.41M
-74.85%43K
Net common stock issuance
--7.66M
--119.88M
-97.10%1.3M
14.86%52.08M
--7.34M
--0
--0
5.91%44.74M
--45.34M
--0
Proceeds from stock option exercised by employees
-10.50%503K
1,495.83%766K
34.41%418K
-12.97%926K
-88.10%5K
29.49%562K
-85.28%48K
18.70%311K
-17.26%1.06M
-75.58%42K
Net other financing activities
----
----
----
----
----
----
----
----
150.00%1K
----
Cash from discontinued financing activities
Financing cash flow
1,351.78%8.16M
251,254.17%120.65M
-96.19%1.72M
14.22%53.01M
16,976.74%7.34M
29.49%562K
-98.60%48K
5.99%45.05M
3,514.41%46.41M
-74.85%43K
Net cash flow
Beginning cash position
0.74%194.05M
-6.16%179.15M
68.25%192.01M
-21.54%114.13M
67.20%190.55M
181.94%192.63M
125.45%190.91M
-21.54%114.13M
-49.41%145.46M
-23.90%113.97M
Current changes in cash
-1,986.41%-43.46M
765.49%14.9M
-116.75%-12.86M
348.53%77.89M
815.63%1.47M
-104.56%-2.08M
110.52%1.72M
226.32%76.78M
77.94%-31.34M
103.73%160K
End cash Position
-20.97%150.59M
0.74%194.05M
-6.16%179.15M
68.25%192.01M
68.25%192.01M
67.20%190.55M
181.94%192.63M
125.45%190.91M
-21.54%114.13M
-21.54%114.13M
Free cash flow
-23.08%-21.72M
22.60%-17.52M
-14.20%-24.58M
-130.78%-82.68M
8.36%-20.88M
26.74%-17.65M
-9.84%-22.64M
-168.00%-21.52M
47.39%-35.83M
-38.40%-22.78M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -25.21%-21.62M19.83%-17.48M-15.03%-24.57M-154.40%-81.07M7.71%-20.65M21.73%-17.26M-9.39%-21.8M-165.73%-21.36M52.37%-31.87M-37.61%-22.37M
Net income from continuing operations -7.69%-26.43M16.18%-25.7M-16.98%-26.37M-3.59%-104.7M-5.08%-26.96M6.01%-24.54M-24.35%-30.65M8.54%-22.55M-17.79%-101.07M-4.94%-25.66M
Operating gains losses --------------1K------------------------
Depreciation and amortization -15.23%540K-10.31%548K-5.70%563K59.70%2.47M2.46%624K64.18%637K102.32%611K141.70%597K58.73%1.55M159.15%609K
Other non cash items 1.24%571K1.08%562K0.00%550K13.62%2.26M8.66%590K5.22%564K4.32%556K45.89%550K58.36%1.99M40.67%543K
Change In working capital -823.93%-3.24M-102.80%-30K20.18%-4.69M-114.02%-6.03M75.06%-875K86.97%-351K151.56%1.07M-111.45%-5.88M93,428.26%43.02M-224.17%-3.51M
-Change in prepaid assets 216.73%600K-136.22%-644K83.29%-349K110.21%529K188.55%1.35M-188.47%-514K283.11%1.78M36.05%-2.09M-81.80%-5.18M-96.40%-1.53M
-Change in payables and accrued expense -137.13%-749K180.80%3.58M-646.72%-1.92M9.12%-3.21M-677.39%-1.15M249.85%2.02M-517.64%-4.43M110.19%351K-221.85%-3.53M-94.48%199K
-Change in other working capital -66.88%-3.09M-179.61%-2.96M41.47%-2.42M-106.48%-3.35M50.50%-1.08M3.84%-1.85M271.52%3.72M-107.14%-4.14M--51.74M---2.18M
Cash from discontinued investing activities
Operating cash flow -25.22%-21.62M19.83%-17.48M-15.03%-24.57M-154.40%-81.07M7.71%-20.65M21.74%-17.26M-9.39%-21.8M-165.73%-21.36M52.37%-31.87M-37.61%-22.37M
Investing cash flow
Cash flow from continuing investing activities -305.27%-30M-476.08%-88.28M-81.18%9.99M330.91%105.95M-34.32%14.77M-78.27%14.62M15,977.40%23.47M139.10%53.09M39.97%-45.88M90.64%22.49M
Net PPE purchase and sale 73.11%-103K94.52%-46K92.73%-12K59.21%-1.62M44.01%-229K81.13%-383K-23.02%-839K80.38%-165K-230.17%-3.96M-101.48%-409K
Net investment purchase and sale -299.34%-29.9M-462.92%-88.23M-81.22%10M356.59%107.56M-34.49%15M-78.35%15M2,836.23%24.31M139.46%53.25M44.27%-41.92M90.83%22.9M
Cash from discontinued investing activities
Investing cash flow -305.27%-30M-476.08%-88.28M-81.18%9.99M330.91%105.95M-34.32%14.77M-78.27%14.62M15,977.40%23.47M139.10%53.09M39.97%-45.88M90.64%22.49M
Financing cash flow
Cash flow from continuing financing activities 1,351.78%8.16M251,254.17%120.65M-96.19%1.72M14.22%53.01M16,976.74%7.34M29.49%562K-98.60%48K5.99%45.05M3,514.41%46.41M-74.85%43K
Net common stock issuance --7.66M--119.88M-97.10%1.3M14.86%52.08M--7.34M--0--05.91%44.74M--45.34M--0
Proceeds from stock option exercised by employees -10.50%503K1,495.83%766K34.41%418K-12.97%926K-88.10%5K29.49%562K-85.28%48K18.70%311K-17.26%1.06M-75.58%42K
Net other financing activities --------------------------------150.00%1K----
Cash from discontinued financing activities
Financing cash flow 1,351.78%8.16M251,254.17%120.65M-96.19%1.72M14.22%53.01M16,976.74%7.34M29.49%562K-98.60%48K5.99%45.05M3,514.41%46.41M-74.85%43K
Net cash flow
Beginning cash position 0.74%194.05M-6.16%179.15M68.25%192.01M-21.54%114.13M67.20%190.55M181.94%192.63M125.45%190.91M-21.54%114.13M-49.41%145.46M-23.90%113.97M
Current changes in cash -1,986.41%-43.46M765.49%14.9M-116.75%-12.86M348.53%77.89M815.63%1.47M-104.56%-2.08M110.52%1.72M226.32%76.78M77.94%-31.34M103.73%160K
End cash Position -20.97%150.59M0.74%194.05M-6.16%179.15M68.25%192.01M68.25%192.01M67.20%190.55M181.94%192.63M125.45%190.91M-21.54%114.13M-21.54%114.13M
Free cash flow -23.08%-21.72M22.60%-17.52M-14.20%-24.58M-130.78%-82.68M8.36%-20.88M26.74%-17.65M-9.84%-22.64M-168.00%-21.52M47.39%-35.83M-38.40%-22.78M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data